Home

David Ian Johnson

CIK 1563432 · Executive Chairman · last filed 2024-10-24

David Ian Johnson is an Executive Chairman who has filed 24 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing, for AIFF, was dated Oct 24, 2024. Across all open-market trades the lifetime net is +$171.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $616.5K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$616.5K

Companies

3

Total Filings

24

Lifetime Open-Market Net

$171.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AIFF Executive Chairman 557,885 $1.10 $616.5K $0 1 2024-10-24
ENVB CEO and Chairman — $1.33 — $0 1 2021-02-17
Alliqua BioMedical, Inc. (ALQA) Delisted President and CEO 332,422 — — $171.7K 15 2017-06-29

Recent Filings

24 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-10-24 AIFF Grant (A) +557,885 $0 EDGAR
2021-02-17 ENVB Grant (A) — $0 EDGAR
2017-06-29 Alliqua BioMedical, Inc. (ALQA) Delisted Grant (A) +300,000 $0 EDGAR
2017-06-26 Alliqua BioMedical, Inc. (ALQA) Delisted Grant (A) +500,000 $0 EDGAR
2017-04-04 Alliqua BioMedical, Inc. (ALQA) Delisted Buy (P) +250,000 $100.0K EDGAR
2016-05-13 Alliqua BioMedical, Inc. (ALQA) Delisted Grant (A) +300,000 $0 EDGAR
2016-02-11 Alliqua BioMedical, Inc. (ALQA) Delisted Grant (A) +59,932 $0 EDGAR
2015-11-09 Alliqua BioMedical, Inc. (ALQA) Delisted Buy (P) +8,650 $25.3K EDGAR
2015-07-06 Alliqua BioMedical, Inc. (ALQA) Delisted Tax (F) −19,191 -$102.7K EDGAR
2015-05-28 Alliqua BioMedical, Inc. (ALQA) Delisted Buy (P) +10,000 $46.5K EDGAR
Showing 1–10 of 24
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.